a public good project by the
Synthesis
Company
of California

© 2026

Paul B.S. Lai | doi.page

0 works0 citations0 h-index

Paul B.S. Lai

University of Hong Kong(HK)

Publications by Year

Research Areas

Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, RNA modifications and cancer, Cancer, Lipids, and Metabolism, Cholangiocarcinoma and Gallbladder Cancer Studies

Most-Cited Works

→ Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade(2014)2,678 cited
→ Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial(2004)893 cited
→ Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments(2015)802 cited
→ Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients(2015)745 cited
→ Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services(2020)708 cited
→ A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma(2005)587 cited

→ Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system(2002)

581 cited

→ Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection(2018)531 cited

Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.(1999)

→ Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing(2012)488 cited